MOYES JAY M

CIK 00011910624 companiesLOS ANGELES, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001191062

Recent Transactions

50 trades

Sale
PUMA BIOTECHNOLOGY, INC.$PBYI
COMMON STOCK
2020-09-16$10.00/sh−9,703→ 31,570 total
Sale
PUMA BIOTECHNOLOGY, INC.$PBYI
COMMON STOCK
2020-09-16$10.00/sh−9,703→ 31,570 total
Award
BioCardia, Inc.$BCDA
Common Stock
2020-06-30+3,750→ 40,511 total
Award
PUMA BIOTECHNOLOGY, INC.$PBYI
STOCK OPTION (RIGHT TO BUY)
2012-04-27+10,000→ 10,000 total
Award
PUMA BIOTECHNOLOGY, INC.$PBYI
STOCK OPTION (RIGHT TO BUY)
2012-04-27+30,000→ 30,000 total
Award
OSIRIS THERAPEUTICS, INC.
Common Stock
2010-05-27$6.46/sh+3,000→ 10,500 total
Award
OSIRIS THERAPEUTICS, INC.
Common Stock
2010-05-27$6.46/sh+3,000→ 10,500 total
Award
OSIRIS THERAPEUTICS, INC.
Common Stock
2008-02-04$12.01/sh+3,000→ 4,500 total
Award
OSIRIS THERAPEUTICS, INC.
Common Stock
2008-02-04$12.01/sh+3,000→ 4,500 total
Sale
MYRIAD GENETICS INC$MYGN
Common Stock
2007-10-15$54.82/sh−86→ 25,282 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Non-Qualified Stock Option (right to buy)
2007-10-15−101→ 30,238 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Non-Qualified Stock Option (right to buy)
2007-10-15−15→ 32,032 total
Sale
MYRIAD GENETICS INC$MYGN
Common Stock
2007-10-15$54.67/sh−2,322→ 25,282 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Common Stock
2007-10-15$12.54/sh+15→ 25,297 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Non-Qualified Stock Option (right to buy)
2007-10-15−29→ 11,327 total
Sale
MYRIAD GENETICS INC$MYGN
Common Stock
2007-10-15$54.81/sh−770→ 25,282 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Non-Qualified Stock Option (right to buy)
2007-10-15−344→ 35,049 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Common Stock
2007-10-15$12.54/sh+2,322→ 27,604 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Common Stock
2007-10-15$12.54/sh+258→ 25,540 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Common Stock
2007-10-15$12.54/sh+200→ 25,482 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Common Stock
2007-10-15$12.54/sh+688→ 25,970 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Common Stock
2007-10-15$12.54/sh+602→ 25,884 total
Sale
MYRIAD GENETICS INC$MYGN
Common Stock
2007-10-15$54.75/sh−168→ 25,282 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Common Stock
2007-10-15$12.54/sh+101→ 25,383 total
Sale
MYRIAD GENETICS INC$MYGN
Common Stock
2007-10-15$54.89/sh−516→ 25,282 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Common Stock
2007-10-15$12.54/sh+344→ 25,626 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Common Stock
2007-10-15$12.54/sh+86→ 25,368 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Common Stock
2007-10-15$12.54/sh+860→ 26,142 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Common Stock
2007-10-15$12.54/sh+258→ 25,540 total
Sale
MYRIAD GENETICS INC$MYGN
Common Stock
2007-10-15$55.53/sh−258→ 25,282 total
Sale
MYRIAD GENETICS INC$MYGN
Common Stock
2007-10-15$54.98/sh−101→ 25,282 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Non-Qualified Stock Option (right to buy)
2007-10-15−688→ 31,344 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Common Stock
2007-10-15$12.54/sh+168→ 25,450 total
Sale
MYRIAD GENETICS INC$MYGN
Common Stock
2007-10-15$54.68/sh−602→ 25,282 total
Sale
MYRIAD GENETICS INC$MYGN
Common Stock
2007-10-15$55.31/sh−258→ 25,282 total
Sale
MYRIAD GENETICS INC$MYGN
Common Stock
2007-10-15$54.71/sh−258→ 25,282 total
Sale
MYRIAD GENETICS INC$MYGN
Common Stock
2007-10-15$54.69/sh−344→ 25,282 total
Sale
MYRIAD GENETICS INC$MYGN
Common Stock
2007-10-15$54.73/sh−860→ 25,282 total
Sale
MYRIAD GENETICS INC$MYGN
Common Stock
2007-10-15$54.93/sh−15→ 25,282 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Common Stock
2007-10-15$12.54/sh+344→ 25,626 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Common Stock
2007-10-15$12.54/sh+258→ 25,540 total
Sale
MYRIAD GENETICS INC$MYGN
Common Stock
2007-10-15$55.09/sh−344→ 25,282 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Common Stock
2007-10-15$12.54/sh+688→ 25,970 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Common Stock
2007-10-15$12.54/sh+172→ 25,454 total
Sale
MYRIAD GENETICS INC$MYGN
Common Stock
2007-10-15$55.32/sh−55→ 25,282 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Non-Qualified Stock Option (right to buy)
2007-10-15−430→ 27,401 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Non-Qualified Stock Option (right to buy)
2007-10-15−263→ 18,447 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Common Stock
2007-10-15$12.54/sh+29→ 25,311 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Common Stock
2007-10-15$12.54/sh+344→ 25,626 total
Sale
MYRIAD GENETICS INC$MYGN
Common Stock
2007-10-15$54.61/sh−1,118→ 25,282 total

Companies

Recent Filings

Address

C/O PUMA BIOTECHNOLOGY, INC. 10880 WILSHIRE BLVD., SUITE 2150

LOS ANGELES, CA, 90024

View on SEC.gov